RBBP1 inhibitors are a class of chemical compounds that specifically target and inhibit the function of RBBP1, also known as Retinoblastoma Binding Protein 1. RBBP1 is a chromatin-associated protein that plays a significant role in transcriptional regulation and chromatin remodeling. It functions by interacting with histones and other chromatin-associated proteins, influencing the structure of chromatin and modulating gene expression. RBBP1 is particularly important in regulating gene silencing, as it is involved in recruiting chromatin remodeling complexes that modify histones to maintain regions of the genome in a repressed state. Inhibitors of RBBP1 typically function by binding to critical domains of the protein, such as those involved in histone interaction, thereby disrupting its ability to regulate chromatin structure and gene expression.
Inhibition of RBBP1 leads to disruptions in the chromatin remodeling processes that it regulates, resulting in altered transcriptional activity. By blocking the function of RBBP1, these inhibitors prevent the proper recruitment of chromatin remodeling complexes, which can lead to the de-repression of genes that are normally kept in a silenced state. Researchers use RBBP1 inhibitors to study the specific roles of this protein in chromatin dynamics and to explore how it contributes to the maintenance of transcriptional regulation across the genome. These inhibitors provide valuable insights into the broader mechanisms of epigenetic regulation, helping scientists understand how chromatin structure is modulated to control gene expression in various cellular contexts. Additionally, RBBP1 inhibitors serve as important tools for investigating the molecular machinery involved in histone modification and gene silencing, offering a deeper understanding of the role of chromatin remodelers like RBBP1 in maintaining cellular function and genomic stability. Through these studies, researchers can gain insights into the molecular pathways that regulate chromatin organization and transcriptional control.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
An HDAC inhibitor that can alter chromatin structure and gene expression, potentially affecting ARID4A's role in transcription regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Another HDAC inhibitor, it impacts chromatin remodeling and could indirectly influence ARID4A activity. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
A CDK4/6 inhibitor affecting cell cycle progression, possibly impacting ARID4A through cell cycle regulation pathways. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
A PARP inhibitor used in DNA repair, which might indirectly affect ARID4A's involvement in chromatin structure and function. | ||||||
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $178.00 $270.00 $712.00 | 3 | |
Similar to Olaparib, it's a PARP inhibitor that could have an indirect impact on ARID4A by modulating DNA repair mechanisms. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
A potent HDAC inhibitor that broadly affects gene expression and chromatin dynamics, potentially influencing ARID4A. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methyltransferase inhibitor, affecting DNA methylation and gene expression, possibly altering ARID4A activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Similar to Decitabine, it affects DNA methylation patterns and could indirectly influence ARID4A's regulatory roles. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
An HDAC inhibitor that can modify chromatin accessibility and gene expression, potentially affecting ARID4A. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Targets HDACs to alter gene expression and chromatin structure, potentially modulating ARID4A's function. | ||||||